drugset / Trial / NCT00060203
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
Phase 1/2
Completed
3 enrolled
Case Comprehensive Cancer Center
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy such as brostallicin use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I/II trial to study the effectiveness of brostallicin in treating patients who have recurrent or refractory multiple myeloma.
Timeline
- Start
- 2002-12
- Primary completion
- 2003-03
- Completion
- 2004-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | brostallicin | Other / unclassified | — | Intravenous |